wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37650748-1CADBC8E-D92B-49A6-A3FE-7692D382ECBF
Q37650748-1CADBC8E-D92B-49A6-A3FE-7692D382ECBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37650748-1CADBC8E-D92B-49A6-A3FE-7692D382ECBF
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.
P2860
Q37650748-1CADBC8E-D92B-49A6-A3FE-7692D382ECBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37650748-1CADBC8E-D92B-49A6-A3FE-7692D382ECBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d153eeb4674b8d9abad9bd41945c80dff8e5943b
P2860
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.